Filed Pursuant to Rule 424(b)(3)
Registration No. 333-35998
Medisys Technologies, Inc.
Prospectus Supplement
(To Prospectus Dated June 9, 2000)
You should read this prospectus supplement and the related
prospectus carefully before you invest. Both documents contain
information you should consider when making your investment
decision.
On September 29, 2000, we issued a drawdown notice to
Treadstone Investment Limited in connection with the equity line of
credit agreement dated as of February 24, 2000, evidencing an equity
draw down facility between us and Treadstone. This notice offered
to sell up to $350,000 of our common stock to Treadstone based on
the formula in the stock purchase agreement, during the twenty-one
trading day period beginning on September 8, 2000 and ending on
October 6, 2000. Pursuant to this formula, Treadstone purchased a
total of 651,441 shares of our common stock at an average purchase
price of $.5373 per share. These purchases resulted in aggregate
proceeds of $350,000 being paid and released from escrow to us by
Treadstone.
The attached prospectus relates to the resale of shares
acquired by Treadstone pursuant to the equity line of credit
agreement. Because Treadstone may sell some or all of these shares,
and because there are currently no agreements, arrangements or
understandings with respect to the sale of any of these shares, we
cannot estimate the actual amount of shares that they will hold
after the completion of the offering.
We expect to use the proceeds of this sale of common stock to
order the CoverTip product for our inventory.
The date of this prospectus supplement is October 12, 2000.
